Day: May 9, 2024

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) held its annual and special meeting of shareholders (the “Meeting”) in a hybrid format on May 9, 2024. A total of 100,706,549 common shares (representing approximately 81% of all issued and outstanding common shares of the Corporation) were represented at the Meeting. WSP hereby announces that shareholders of the Corporation (the “Shareholders”) voted in favour of all items of business put forth at the Meeting by the Corporation. The complete voting results for each item of business at the Meeting are presented below. ELECTION OF DIRECTORSThe Board of Directors of the Corporation had fixed at eight the number of directors to be elected at the Meeting. Following the vote at the Meeting, each of the eight nominees listed in the Corporation’s...

All amounts are stated in United States dollars unless otherwise indicatedRevenue of $11.7 million Robust sales pipeline with 2 additional customer wins Total Contract Value (“TCV”)(1) bookings of $21.8 million Gross margin of 58% Adjusted EBITDA(1) loss of $2.3 million Adjusted EPS(1) loss of $(0.98) $12.0 million of cashTORONTO, May 09, 2024 (GLOBE NEWSWIRE) — Optiva Inc. (“Optiva” or “the Company”) (TSX:OPT), a leader in powering the telecom industry with cloud-native billing, charging and revenue management software on private and public clouds, today released its first quarter financial results for the three-month period ended March 31, 2024. Demonstrating continued momentum, Optiva signed contracts with two new customers leveraging telecom opportunities in Africa during the three-month period ended March 31, 2024. Over...

WEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that the release of the Company’s financial results for the three and six months ended March 31, 2024 and the conference call to discuss the results that were originally scheduled for Friday, May 10, 2024 are being rescheduled to provide the Company additional time to complete the accounting analyses related to certain matters. Specifically, as previously disclosed, the Company has been cooperating with the U.S. Department of Justice (the “DOJ”) and other authorities related to an investigation by those authorities into various matters relating...

VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) — AIP Realty Trust (the “Trust” or “AIP”) (TSXV: AIP.U) today announces that the failure to file cease trade order (the “FFCTO”) issued by the British Columbia Securities Commission on May 6, 2024 has been revoked effective today and Canadian trading in the class A trust units of the Trust will resume. The FFCTO was issued following the Trust’s delay in filing its audited consolidated annual financial statements, management’s discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2023 and accompanying management discussion and analysis prior to the applicable deadline. About AIP Realty TrustAIP Realty Trust is a real estate investment trust with a growing portfolio of AllTrades branded Serviced Industrial Business Suites (“SIBS”)...

ISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (NYSE:PFS) (the “Company”), the holding company for Provident Bank (the “Bank”), today announced the pricing of its offering of $225 million of its 9.00% fixed-to-floating rate subordinated notes due 2034 (the “Notes”) in a registered public offering (the “Offering”). The Notes will initially bear interest at 9.00% per annum, with interest payable semiannually in arrears, commencing on the issue date, to, but excluding, May 15, 2029. Commencing May 15, 2029, the interest rate on the Notes will reset quarterly to a floating rate per annum equal to a benchmark rate that is expected to be Three-Month Term SOFR (which is defined in the Notes) plus 476.5 basis points, with interest payable quarterly in arrears. The Company may redeem the Notes, in whole...

30 month median overall survival (OS); median OS independent of patient CPS score ORR 34% (CPS≥1); 48% (CPS≥20) Phase 3 registrational trial planned to initiate in 2024 PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, hosted a Key Opinion Leader event on May 8, 2024 during which prominent experts in head and neck squamous cell cancer (“HNSCC”) discussed positive, updated VERSATILE-002 data and the unmet need in HPV16-positive HNSCC. A replay of the event can be found here.The VERSATILE-002 trial is evaluating Versamune® HPV + KEYTRUDA® (pembrolizumab) in patients with HPV16-positive HNSCC. Median...